Despite the high expression levels of these genes in glioma cases, no statistically significant differences were observed between male and female patients (DJ-1, GDF15, and MFGE8: p = 0.563, p = 0.490, and p = 0.831, respectively). This evidence concerns the gene PARK7 and central nervous system cancer.